This presentation is the property of its rightful owner.
Sponsored Links
1 / 31

中国脑血管病防治指南 PowerPoint PPT Presentation


  • 71 Views
  • Uploaded on
  • Presentation posted in: General

中国脑血管病防治指南. 中国脑血管病防治指南编写委员会 第二节 脑梗死. 脑梗死指因脑部血液循环障碍,缺血、缺氧所致的局限性脑组织的缺血性坏死或软化。血管壁病变、血液成分病变和血液动力学改变是引起脑梗死的主要原因。脑梗死发病率为 110 / 10 万人口,约占全部脑卒中的 60 %一 80 %。脑梗死的诊治重在根据发病时间、临床表现、病因及病理进行分型分期,综合全身状态,实施个体化治疗。在超急性期和急性期采取积极、合理的治疗措施尤为重要。. 一、诊断. ( 一 ) 临床特点 1 、多数在静态下急性起病,动态起病者以心源性脑梗死多见,部分病例的前驱可有 TIA 的表现。

Download Presentation

中国脑血管病防治指南

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


4727447


4727447

  • 110106080


4727447

  • ()

  • 1TIA

  • 2

  • 3

  • ()

  • 1


4727447

  • 2

  • (1)(CT)

  • CT

  • (6)CT


4727447

  • (2)(MRI)

  • MRI(T1T2)50(DWI)8810095100(PWI)

  • MRICT(GRE)


4727447

  • (3)(TCD)

  • (4)

  • (DSA)DSA

  • (MRA)CT(CTA)


4727447

  • (5)(PET)

  • PET15PET(rCBF)(OEF)PETPET

  • (6)CT

  • CTCT


4727447

  • (7)(SPECT)

  • () (OCSP)

  • (36h)(OCSP)CMRI


4727447

  • OCSP

  • 1(TACI)(McA)() ()()McA

  • 2PACITACTMcAAcA


4727447

  • 3(PoCI

  • 4(LAcI)


4727447

  • (1)(26)(6)36


4727447

  • ()()

  • ()()

  • ()


4727447

  • 1

  • 1)

  • (1) (1)(NIHSS 722)

  • (2) 36

  • (3)()


4727447

  • (4)3321

  • (5)(185mmHg110mmHg)

  • (6) INR1.548APTT100000mm3

  • 750mg/dl(2.7mmol/L)

  • 8

  • (9) CT

  • (10)


4727447

  • 2)

  • (1)

  • 6615030

  • 756cT180100mmHgTIA

  • 39C


4727447

  • (2)(rtPA)

  • 0.9mg/kg(90mg)10160

  • rtPA1563024

  • rtPACT

  • 21563024


4727447

  • 185mmHg105mmHg

  • 180230mmHg1210mg labetalol1020300mg28mg/min

  • 140mmHg0.5mg/kg/min


4727447

  • c T

  • NIHSS22

  • 75

  • l85110mmHg


4727447

  • 3

  • 31506

  • reteplaseanistreplase


4727447

  • 3)

  • II(rproUK)rproUK 90RankinO2rProUK4025(Po.043)(I)rprouK6618(P0.001)


4727447

  • 24rproUX102(Po.06)

  • rtPArproUKrtPA

  • 6


4727447

  • 13rtPA36

  • (2) 6

  • (3)


4727447

  • 2

  • (1)

  • 6130mg/dl


4727447

  • (2)

  • 72

  • (3) Ancrod

  • ancrod3100mg/dl(6


4727447

  • (1) (12)

  • (2)

  • 3


4727447

  • (1) (unfactionated heparinUFH)

  • (IST)

  • (2) (Low Molecular WeightLMW)

  • 1063

  • (3)

  • TOAST


4727447

  • (1)

  • (2) 24

  • (3)

  • csc


4727447

  • 4

  • (1)

  • (ISTcAsT)

  • (2)

  • IIbIIIa


4727447

  • (1) 48)

  • (2) 24

  • (3) 150300mgd4

  • 5


4727447

  • 6


4727447

  • ()

  • NMDAGABAICAM-1


  • Login